Cullinan Associates’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.8M | Sell |
46,424
-4,807
| -9% | -$429K | 0.36% | 62 |
|
|
2026
Q1 | $3.68M | Buy |
51,231
+3,844
| +8% | +$296K | 0.3% | 69 |
|
|
2025
Q4 | $3.76M | Sell |
47,387
-893
| -2% | -$70.4K | 0.25% | 74 |
|
|
2025
Q3 | $3.64M | Buy |
48,280
+813
| +2% | +$55.7K | 0.24% | 78 |
|
|
2025
Q2 | $3.27M | Buy |
47,467
+3,008
| +7% | +$197K | 0.22% | 82 |
|
|
2025
Q1 | $3.01M | Buy |
44,459
+4,841
| +12% | +$290K | 0.21% | 88 |
|
|
2024
Q4 | $1.78M | Sell |
39,618
-83,064
| -68% | -$4.66M | 0.11% | 113 |
|
|
2024
Q3 | $7.12M | Buy |
122,682
+37,395
| +44% | +$2.18M | 0.4% | 56 |
|
|
2024
Q2 | $5.04M | Sell |
85,287
-34,210
| -29% | -$2.14M | 0.29% | 71 |
|
|
2024
Q1 | $9.53M | Buy |
119,497
+11,444
| +11% | +$874K | 0.53% | 47 |
|
|
2023
Q4 | $8.53M | Sell |
108,053
-41,162
| -28% | -$2.93M | 0.48% | 50 |
|
|
2023
Q3 | $10.4M | Sell |
149,215
-14,575
| -9% | -$1.03M | 0.61% | 40 |
|
|
2023
Q2 | $11.3M | Sell |
163,790
-31,753
| -16% | -$2.26M | 0.62% | 43 |
|
|
2023
Q1 | $14.5M | Buy |
195,543
+5,426
| +3% | +$455K | 0.85% | 31 |
|
|
2022
Q4 | $17.7M | Buy |
190,117
+2,569
| +1% | +$248K | 0.98% | 21 |
|
|
2022
Q3 | $17.9M | Buy |
187,548
+4,167
| +2% | +$412K | 1.13% | 18 |
|
|
2022
Q2 | $17M | Buy |
183,381
+11,213
| +7% | +$1.09M | 1.04% | 22 |
|
|
2022
Q1 | $17.4M | Buy |
172,168
+2,399
| +1% | +$252K | 0.91% | 26 |
|
|
2021
Q4 | $17.5M | Buy |
169,769
+16,488
| +11% | +$1.52M | 0.89% | 29 |
|
|
2021
Q3 | $13M | Buy |
153,281
+10,605
| +7% | +$888K | 0.72% | 38 |
|
|
2021
Q2 | $11.9M | Buy |
142,676
+28,917
| +25% | +$2.37M | 0.67% | 44 |
|
|
2021
Q1 | $8.56M | Buy |
113,759
+2,261
| +2% | +$165K | 0.49% | 59 |
|
|
2020
Q4 | $7.62M | Sell |
111,498
-8,787
| -7% | -$572K | 0.46% | 62 |
|
|
2020
Q3 | $7.03M | Buy |
120,285
+3,939
| +3% | +$245K | 0.45% | 56 |
|
|
2020
Q2 | $7.56M | Sell |
116,346
-527
| -0.5% | -$33.2K | 0.53% | 42 |
|
|
2020
Q1 | $6.93M | Buy |
116,873
+3,402
| +3% | +$227K | 0.57% | 49 |
|
|
2019
Q4 | $8.43M | Buy |
113,471
+8,112
| +8% | +$570K | 0.56% | 46 |
|
|
2019
Q3 | $6.64M | Buy |
105,359
+17,047
| +19% | +$1.01M | 0.47% | 61 |
|
|
2019
Q2 | $4.81M | Buy |
88,312
+4,818
| +6% | +$259K | 0.35% | 81 |
|
|
2019
Q1 | $4.5M | Sell |
83,494
-8,630
| -9% | -$533K | 0.34% | 86 |
|
|
2018
Q4 | $6.04M | Buy |
92,124
+1,209
| +1% | +$90.2K | 0.5% | 50 |
|
|
2018
Q3 | $7.16M | Buy |
90,915
+3,006
| +3% | +$215K | 0.52% | 53 |
|
|
2018
Q2 | $5.66M | Buy |
87,909
+12,001
| +16% | +$791K | 0.43% | 68 |
|
|
2018
Q1 | $4.72M | Sell |
75,908
-32,167
| -30% | -$2.31M | 0.36% | 82 |
|
|
2017
Q4 | $7.83M | Sell |
108,075
-10,593
| -9% | -$770K | 0.58% | 42 |
|
|
2017
Q3 | $9.65M | Buy |
118,668
+3,498
| +3% | +$277K | 0.74% | 38 |
|
|
2017
Q2 | $9.27M | Buy |
115,170
+10,060
| +10% | +$794K | 0.72% | 41 |
|
|
2017
Q1 | $8.25M | Buy |
105,110
+49,400
| +89% | +$3.94M | 0.67% | 40 |
|
|
2016
Q4 | $4.4M | Buy |
55,710
+480
| +0.9% | +$38.8K | 0.37% | 73 |
|
|
2016
Q3 | $4.92M | Hold |
55,230
| – | – | 0.42% | 68 |
|
|
2016
Q2 | $5.29M | Buy |
55,230
+50
| +0.1% | +$4.98K | 0.43% | 63 |
|
|
2016
Q1 | $5.72M | Buy |
55,180
+1,000
| +2% | +$97.2K | 0.49% | 56 |
|
|
2015
Q4 | $5.3M | Buy |
54,180
+16,010
| +42% | +$1.57M | 0.46% | 53 |
|
|
2015
Q3 | $3.68M | Buy |
38,170
+850
| +2% | +$89.4K | 0.34% | 67 |
|
|
2015
Q2 | $3.91M | Sell |
37,320
-5,900
| -14% | -$603K | 0.32% | 76 |
|
|
2015
Q1 | $4.46M | Sell |
43,220
-1,940
| -4% | -$196K | 0.35% | 64 |
|
|
2014
Q4 | $4.35M | Buy |
45,160
+7,205
| +19% | +$635K | 0.46% | 37 |
|
|
2014
Q3 | $3.02M | Buy |
37,955
+5,280
| +16% | +$416K | 0.34% | 46 |
|
|
2014
Q2 | $1.87M | Sell |
32,675
-3,000
| -8% | -$227K | 0.3% | 45 |
|
|
2014
Q1 | $2.67M | Sell |
35,675
-200
| -0.6% | -$14.1K | 0.3% | 48 |
|
|
2013
Q4 | $2.57M | Sell |
35,875
-2,500
| -7% | -$161K | 0.3% | 48 |
|
|
2013
Q3 | $2.18M | Buy |
38,375
+3,000
| +8% | +$179K | 0.29% | 48 |
|
|
2013
Q2 | $2.02M | Buy |
+35,375
| New | +$2.05M | 0.27% | 49 |
|
Other funds holding CVS
Cullinan Associates's CVS Position: Q2 2026 in Review
Cullinan Associates reduced its CVS Health (CVS) stake by 9.4% in Q2 2026, selling an estimated $429K and leaving 46,424 shares worth $4.8M. The position accounts for 0.36% of the portfolio, ranked #62.
Cullinan Associates first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.9M in Q3 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Cullinan Associates held 46,424 shares of CVS Health worth $4.8M as of Q2 2026.
- Cullinan Associates sold 4,807 CVS Health shares in Q2 2026, an estimated $429K.
- CVS Health made up 0.36% of Cullinan Associates's portfolio in Q2 2026, its #62 holding.
- Cullinan Associates first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Cullinan Associates's CVS Health position peaked at $17.9M in Q3 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Cullinan Associates's 13F filing for Q2 2026, filed 29 Jul 2026.